Tag: genomics
-
Broad Institute in Crispr Licensing Program
One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology.
-
Little Health Impact Found from Engineered Mosquitoes
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans.
-
Feasibility, Safety Shown for Personal Tumor Vaccine
A pilot study among individuals with a form of skin cancer shows a vaccine aiming at proteins specific to a person’s tumor is safe and can generate a complex immune response attacking the tumor.
-
Simple, Inexpensive Pathogen Detector Developed
A simple and inexpensive detection device is being created to find disease-causing microbes in samples of food, water, and human specimens.
-
Noninvasive Prenatal Testing is a Safe Way to Screen for Genetic Abnormalities
Noninvasive prenatal testing is a way for parents to screen their unborn child for a variety of chromosomal anomalies.
-
Engineered Algae Doubles Bio-Oil Content
An industry biotechnology team created a genetically-engineered variety of algae that doubles its oil content without limiting its ability to grow.
-
Coalition to Make 10,000 Open-Access Synthetic Genes
A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers.
-
First Agricultural Crispr Products Expected by 2020
While the genome editing technique known as Crispr is generating discussion in the health field, its first commercial applications are likely to be in agriculture.
-
Precision Medicine Trial Shows Reduced Pain, Opioid Use
A large-scale clinical trial tracking pain treatments guided by genetic testing shows large majorities of participants report less pain, with fewer individuals using opioid drugs.
-
Bacteria Engineered to Act as Long-Term Gut Sensors
A bioengineering team developed a synthetic form of bacteria that live in the gut, and detect inflammation in lab mice for 6 months.